What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
The scientist’s investigation covers issues in Internal medicine, Ulcerative colitis, Surgery, Gastroenterology and Crohn's disease.
His biological study spans a wide range of topics, including Physical therapy, Colitis and Inflammatory bowel disease.
His Inflammatory bowel disease research includes themes of Colonoscopy, Pharmacokinetics and Interquartile range.
His Surgery study combines topics in areas such as Crohn's Disease Activity Index, Colectomy, Placebo and Disease.
The various areas that he examines in his Gastroenterology study include Microbiome, Cumulative incidence, Systemic lupus erythematosus, Proctocolectomy and Severity of illness.
The Crohn's disease study combines topics in areas such as Inflammation, C-reactive protein, Magnetic resonance imaging and Transplantation.
His most cited work include:
- Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. (1712 citations)
- Vedolizumab as induction and maintenance therapy for ulcerative colitis. (1388 citations)
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis (1222 citations)
What are the main themes of his work throughout his whole career to date?
Gert Van Assche focuses on Internal medicine, Gastroenterology, Crohn's disease, Ulcerative colitis and Inflammatory bowel disease.
His study ties his expertise on Surgery together with the subject of Internal medicine.
His Gastroenterology research integrates issues from Mucosal healing, Adverse effect, Placebo, Prospective cohort study and C-reactive protein.
Gert Van Assche has researched Crohn's disease in several fields, including Radiology and Endoscopy.
Gert Van Assche has included themes like Therapeutic drug monitoring, Clinical trial and Colitis in his Ulcerative colitis study.
His studies deal with areas such as Colonoscopy, Intestinal mucosa and Immunology as well as Inflammatory bowel disease.
He most often published in these fields:
- Internal medicine (53.36%)
- Gastroenterology (40.13%)
- Crohn's disease (36.34%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (53.36%)
- Ulcerative colitis (35.92%)
- Gastroenterology (40.13%)
In recent papers he was focusing on the following fields of study:
Gert Van Assche mostly deals with Internal medicine, Ulcerative colitis, Gastroenterology, Crohn's disease and Inflammatory bowel disease.
His research integrates issues of Area under the curve, Randomized controlled trial, Oncology and Ustekinumab in his study of Ulcerative colitis.
He combines subjects such as Interquartile range, Adverse effect, Necrosis, Prospective cohort study and C-reactive protein with his study of Gastroenterology.
His work carried out in the field of Crohn's disease brings together such families of science as Abscess, Surgery, Retrospective cohort study and Innate lymphoid cell.
His research in Surgery intersects with topics in Colonoscopy and Hazard ratio.
His studies in Inflammatory bowel disease integrate themes in fields like Tumor necrosis factor alpha, Pharmacokinetics, Immune system, Intensive care medicine and Endoscopy.
Between 2017 and 2021, his most popular works were:
- Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases. (67 citations)
- Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC. (66 citations)
- New treatment options for inflammatory bowel diseases. (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His main research concerns Internal medicine, Gastroenterology, Crohn's disease, Ulcerative colitis and Vedolizumab.
His studies in Ustekinumab and Colitis are all subfields of Internal medicine research.
His Gastroenterology research includes elements of Therapeutic drug monitoring, Cell, Infliximab and Maintenance therapy.
His Crohn's disease research incorporates themes from Adalimumab and Randomized controlled trial, Surgery, Retrospective cohort study.
His Surgery research is multidisciplinary, incorporating perspectives in Colectomy, Severity of illness and Ileum.
His Ulcerative colitis research incorporates elements of Treatment goals, Inflammatory bowel disease and Multicenter study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
